ResearchMoz

Air Liquide Market Share Analysis

GlobalData
Published Date » 2011-11-30
No. Of Pages » 83
   
   
 GlobalDatas new report, Air Liquide Market Share Analysis provides in-depth information on Air Liquides market position in the different medical equipment markets it operates in. The report provides Air Liquides market share information in one key market categories Anesthesia and respiratory devices. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the companys business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments. 
   
 This report is built using data and information sourced from proprietary databases, primary and secondary research and...
Table of Contents

1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 9

2 Introduction 10
2.1 What Is This Report About? 10

3 Definitions of Markets/Categories Covered 11
3.1 Anesthesia and Respiratory Devices 11
3.1.1 Airway Anesthesia Disposables 11
3.1.2 Anesthesia Machines 11
3.1.3 Pain Management Devices 11
3.1.4 Regional Anesthesia Disposables 11
3.1.5 Respiratory Devices 11
3.1.6 Respiratory Disposables 11
3.1.7 Respiratory Measurement Devices 12
3.1.8 Sleep Apnea Diagnostic Systems 12

4 Company Snapshot 13
4.1 Key Information 13
4.2 Company Overview 13
4.3 Financial Performance 13
4.4 SWOT Snapshot 13

5 Business Description 14
5.1 Business Overview 14
5.2 Engineering and Construction 14
5.2.1 Overview 14
5.2.2 Financials 14
5.2.3 Key Strategies 14
5.3 Gas and Services 15
5.3.1 Overview 15
5.3.2 Financials 15
5.3.3 Capital Expenditure 15
5.3.4 Market View 15
5.3.5 Key Strategies 15
5.4 Other Activities 15
5.4.1 Overview 15
5.4.2 Financials 15
5.4.3 Key Strategies 16
5.5 Major Products and Services 17
5.5.1 Overview 17

6 History 18

7 SWOT Analysis 23
7.1 Overview 23
7.2 AIR LIQUIDE Strengths 23
7.2.1 Expanding Operating Margin 23
7.2.2 Presence in Respiratory Care 24
7.2.3 Strong Research and Development Capabilities 24
7.2.4 Strategic Acquisitions 24
7.2.5 Diversified Operations 25
7.2.6 Global Presence 25
7.3 AIR LIQUIDE Weaknesses 25
7.3.1 Ineffective Patent Systems 25
7.3.2 Declining Market Share in the Sector 25
7.3.3 Limited Liquidity Position 26
7.4 AIR LIQUIDE Opportunities 26
7.4.1 Solar Power Market 26
7.4.2 ALMA: Strategic Program 26
7.4.3 Growing COPD Market 26
7.4.4 Market Potential: Sleep Apnea 27
7.4.5 Growth Opportunities in Emerging Markets 27
7.4.6 Rising Demand from Healthcare Sector 27
7.5 AIR LIQUIDE Threats 27
7.5.1 Global Economic Slowdown 27
7.5.2 Environmental Regulations 28
7.5.3 Increasing Competition 28

8 Competitors 29

9 Competitive Landscape 30
9.1 Anesthesia and Respiratory Devices, Global, Company Share (%), 2009 30

10 AIR LIQUIDE Medical Equipment Market Share Analysis 32
10.1 AIR LIQUIDE, Anesthesia and Respiratory Devices, Global, Market Share (2009) 32
10.2 AIR LIQUIDE, Asia-Pacific, Market Share (2009) 34
10.3 AIR LIQUIDE, Europe, Market Share (2009) 35
10.4 AIR LIQUIDE, Middle East and Africa, Market Share (2009) 37
10.5 AIR LIQUIDE, North America, Market Share (2009) 38
10.6 AIR LIQUIDE, South and Central America, Market Share (2009) 39

11 AIR LIQUIDE Medical Equipment Market Share Analysis by Category 40
11.1 AIR LIQUIDE, Anesthesia and Respiratory Devices, Global, Category Revenue Share (2009) 40
11.2 AIR LIQUIDE, Asia-Pacific, Category Revenue Share (2009) 41
11.2.1 AIR LIQUIDE, China, Category Revenue Share (2009) 41
11.3 AIR LIQUIDE, Europe, Category Revenue Share (2009) 42
11.3.1 AIR LIQUIDE, France, Category Revenue Share (2009) 42
11.3.2 AIR LIQUIDE, Germany, Category Revenue Share (2009) 42
11.3.3 AIR LIQUIDE, Italy, Category Revenue Share (2009) 43
11.3.4 AIR LIQUIDE, Spain, Category Revenue Share (2009) 43
11.3.5 AIR LIQUIDE, United Kingdom, Category Revenue Share (2009) 43
11.3.6 AIR LIQUIDE, Other Europe, Category Revenue Share (2009) 44
11.4 AIR LIQUIDE, Middle East and Africa, Category Revenue Share (2009) 45
11.5 AIR LIQUIDE, North America, Category Revenue Share (2009) 46
11.5.1 AIR LIQUIDE, Canada, Category Revenue Share (2009) 46
11.5.2 AIR LIQUIDE, United States, Category Revenue Share (2009) 46
11.6 AIR LIQUIDE, South and Central America, Category Revenue Share (2009) 47
11.6.1 AIR LIQUIDE, Brazil, Category Revenue Share (2009) 47

12 Key Employees 48

13 Key Employee Biographies 50

14 Company Statement 51

15 Locations And Subsidiaries 53
15.1 Head Office 53
15.2 Other Locations & Subsidiaries 53

16 Financial Deals Landscape 57
16.1 AIR LIQUIDE, Deals Volume Summary, 2005 to YTD 2010 57

17 AIR LIQUIDE Detailed Deal Summary 60
17.1 Divestiture - Company 60
17.1.1 Apria Healthcare Group Acquires Vitalaire Healthcare From Air Liquide 60
17.2 Divestiture - Assets 61
17.2.1 Respironics Acquires Business Unit Of Markos Mefar 61
17.2.2 Praxair Acquires German Industrial Gas Business From Air Liquide 62
17.2.3 Air Liquide Completes Bond Issue Of $560 Million 63
17.3 Acquisition 64
17.3.1 Air Liquide Completes Acquisition Of 100% Stake In DinnoSante 64
17.3.2 Air Liquide Acquires Pacific Science 65
17.3.3 Air Liquide Acquires Air Separation 66
17.3.4 Air Liquide Acquires Comcare Medical 67
17.3.5 Air Liquide Acquires Electrocare Systems & Services 68
17.3.6 American Air Liquide Holdings Acquires Scott Specialty Gases 69
17.3.7 Air Liquide Acquires Celki International 70
17.3.8 Air Liquide Acquires Linde Gas From Linde 71
17.3.9 Air Liquide Acquires Japan Air Gases 73
17.3.10 Air Liquide Acquires Aiolos Medical 74
17.3.11 VitalAire Acquires Rubel Atem-und Sauerstoffgerate 75
17.3.12 Vitalaire Acquires Braun Meditec 76
17.3.13 Schulke & Mayr Completes Acquisition Of Arcana Hygienesysteme 77

18 Appendix 78
18.1 Research Methodology 79
18.2 Secondary Research 79
18.3 Primary Research 80
18.4 Models 80
18.5 Forecasts 80
18.6 Expert Panels 81
18.7 GlobalData Consulting 81
18.8 Currency Conversion 82
18.9 Contact Us 83
18.10 Disclaimer 83

List of Tables

 
Table 1: AIR LIQUIDE, Key Facts, 2009 13
Table 2: AIR LIQUIDE, SWOT Analysis, 2009 23
Table 3: Anesthesia and Respiratory Devices, Global, Company Share by Revenue ($m), 2009 31
Table 4: AIR LIQUIDE, Anesthesia and Respiratory Devices, Global, Revenue ($m) and Market Share (%), 2009 33
Table 5: AIR LIQUIDE, Anesthesia and Respiratory Devices, Asia-Pacific, Revenue ($m) and Market Share (%), 2009 34
Table 6: AIR LIQUIDE, Anesthesia and Respiratory Devices, Europe, Revenue ($m) and Market Share (%), 2009 36
Table 7: AIR LIQUIDE, Anesthesia and Respiratory Devices, Middle East and Africa, Revenue ($m) and Market Share (%), 2009 37
Table 8: AIR LIQUIDE, Anesthesia and Respiratory Devices, North America, Revenue ($m) and Market Share (%), 2009 38
Table 9: AIR LIQUIDE, Anesthesia and Respiratory Devices, South and Central America, Revenue ($m) and Market Share (%), 2009 39
Table 10: AIR LIQUIDE, Anesthesia and Respiratory Devices, Global, Revenue ($m) and Market Share (%) by Category, 2009 40
Table 11: AIR LIQUIDE, Anesthesia and Respiratory Devices, Asia-Pacific, Revenue ($m) and Market Share (%) by Category, 2009 41
Table 12: AIR LIQUIDE, Anesthesia and Respiratory Devices, China, Revenue ($m) and Market Share (%) by Category, 2009 41
Table 13: AIR LIQUIDE, Anesthesia and Respiratory Devices, Europe, Revenue ($m) and Market Share (%) by Category, 2009 42
Table 14: AIR LIQUIDE, Anesthesia and Respiratory Devices, France, Revenue ($m) and Market Share (%) by Category, 2009 42
Table 15: AIR LIQUIDE, Anesthesia and Respiratory Devices, Germany, Revenue ($m) and Market Share (%) by Category, 2009 42
Table 16: AIR LIQUIDE, Anesthesia and Respiratory Devices, Italy, Revenue ($m) and Market Share (%) by Category, 2009 43
Table 17: AIR LIQUIDE, Anesthesia and Respiratory Devices, Spain, Revenue ($m) and Market Share (%) by Category, 2009 43
Table 18: AIR LIQUIDE, Anesthesia and Respiratory Devices, United Kingdom, Revenue ($m) and Market Share (%) by Category, 2009 43
Table 19: AIR LIQUIDE, Anesthesia and Respiratory Devices, Other Europe, Revenue ($m) and Market Share (%) by Category, 2009 44
Table 20: AIR LIQUIDE, Anesthesia and Respiratory Devices, Middle East and Africa, Revenue ($m) and Market Share (%) by Category, 2009 45
Table 21: AIR LIQUIDE, Anesthesia and Respiratory Devices, North America, Revenue ($m) and Market Share (%) by Category, 2009 46
Table 22: AIR LIQUIDE, Anesthesia and Respiratory Devices, Canada, Revenue ($m) and Market Share (%) by Category, 2009 46
Table 23: AIR LIQUIDE, Anesthesia and Respiratory Devices, United States, Revenue ($m) and Market Share (%) by Category, 2009 46
Table 24: AIR LIQUIDE, Anesthesia and Respiratory Devices, South and Central America, Revenue ($m) and Market Share (%) by Category, 2009 47
Table 25: AIR LIQUIDE, Anesthesia and Respiratory Devices, Brazil, Revenue ($m) and Market Share (%) by Category, 2009 47
Table 26: AIR LIQUIDE, Key Employees 48
Table 27: AIR LIQUIDE, Other Locations 53
Table 28: AIR LIQUIDE, Subsidiaries 54
Table 29: AIR LIQUIDE, Deals Volume Summary, 2005 to YTD 2010 58
Table 30: AIR LIQUIDE, Deals Summary, 2005 to YTD 2010 59
Table 31: Apria Healthcare Group Acquires Vitalaire Healthcare From Air Liquide 60
Table 32: Respironics Acquires Business Unit Of Markos Mefar 61
Table 33: Praxair Acquires German Industrial Gas Business From Air Liquide 62
Table 34: Air Liquide Completes Bond Issue Of $560 Million 63
Table 35: Air Liquide Completes Acquisition Of 100% Stake In DinnoSante 64
Table 36: Air Liquide Acquires Pacific Science 65
Table 37: Air Liquide Acquires Air Separation 66
Table 38: Air Liquide Acquires Comcare Medical 67
Table 39: Air Liquide Acquires Electrocare Systems & Services 68
Table 40: American Air Liquide Holdings Acquires Scott Specialty Gases 69
Table 41: Air Liquide Acquires Celki International 70
Table 42: Air Liquide Acquires Linde Gas From Linde 71
Table 43: Air Liquide Acquires Japan Air Gases 73
Table 44: Air Liquide Acquires Aiolos Medical 74
Table 45: VitalAire Acquires Rubel Atem-und Sauerstoffgerate 75
Table 46: Vitalaire Acquires Braun Meditec 76
Table 47: Schulke & Mayr Completes Acquisition Of Arcana Hygienesysteme 77
Table 48: USD to Local Currency, Average Exchange Rate 2009 82

List of Figures

 
Figure 1: Anesthesia and Respiratory Devices, Global, Company Share (%), 2009 30
Figure 2: AIR LIQUIDE, Anesthesia and Respiratory Devices, Global, Market Share (%), 2009 32
Figure 3: AIR LIQUIDE, Anesthesia and Respiratory Devices, Europe, Market Share (%), 2009 35
Figure 4: AIR LIQUIDE, Anesthesia and Respiratory Devices, North America, Market Share (%), 2009 38
Figure 5: AIR LIQUIDE, Deals Volume Summary, 2005 to YTD 2010 57

Upcoming Reports:

Greece: umbrellas market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the umbrellas market in Greece and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the umbrellas market in Greece, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview of the main...
Chronic Kidney Disease Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2014 - 2020
By - Transparency Market Research
Chronic kidney disease (CKD), which is also known as chronic renal disease, is caused due to progressive loss of proper functioning of the kidneys and associated renal system over a longer period of time either months or years. Chronic kidney diseases often go unnoticed, as the individuals suffering from the disease are seen to be having non-specific symptoms like feeling unwell, or loss of appetite among others. Many a times, patients suffering from a chronic kidney disorder are diagnosed due to their screening for diabetes, high blood pressure and others.  However, patients...
Poland: chlorine market
By - Williams and Marshal Strategy
scribe the state of the chlorine market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview of the main market participants, the price fluctuations, the growth and demand drivers of the market and the factors, influencing its development. Last but not least, the report presents a general overview of the economy of Poland in...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Order cancellations not a sign of market slump: Airbus
Jul 31, 2014  
Leading aircraft manufacturer Airbus on Wednesday said that the recent wave of order cancellations for its commercial jetliners do not mean that the market has declined. The market is still strong and single-aisle jets deals are likely to return later. A total of 225 Airbus cancellations were reported since the beginning of this year. Of these, Dubai’s Emirates Airlines alone...
Leading Australian Universities Want to Hike Fees, Enroll Fewer Students
Jul 31, 2014  
Australia’s prestigious group of top eight universities, also known as the Group of Eight (Go8), has indicated plans of increasing tuition fees while reducing the number of students they enroll, a reform-backer has predicted. These decisions could be made if the universities are deregulated .  Arguing for this decision, the chairman of Go8, and vice chancellor of the ANU, Ian...
Bristol-Myers Squibb Posts USD 3.9 billion Revenues in 2014 Second Quarter
Jul 30, 2014  
Leading bio-pharmaceutical company Bristol-Myers Squibb has registered revenues of USD 3.9 billion in the 2014 second quarter. This marks a 4% decrease from the same period in 2013. The global revenues of the company (excluding the divested Diabetes Alliance), saw a 7% increase. In this quarter, the company’s results were underlined by steady global sales of nearly each of its...
Novartiss Simbrinza gets approval from the EU
Jul 30, 2014  
Glaucoma patients in Europe can easily obtain Novartis’ Simbrinza eye drops which are a combination of brimonidine tartrate and brinzolamide and it is without a beta-blocker. This eye drop has got the approval of the European Commission. Unlike the inefficient treatment provided by monotherapy, this eye drop aims at treating intraocular pressure or IOP in adults with ocular hypertension...
Second Treaty Between Zealand And Boehringer Ingelheim
Jul 30, 2014  
Denmark based Pharma group Zealand Pharma and Germany’s Boehringer Ingelheim have signed an accord to formulate new medicines for advanced and effective treatment of cardio-metabolic maladies. The collaboration between these two Pharma groups involves a new therapeutic peptide project from the list of preclinical programs of Zealand Pharma.  Both these companies are aiming...